Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by wagyusteakon Jul 02, 2020 5:39pm
54 Views
Post# 31218107

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Looking for Paladin price history since begining

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Looking for Paladin price history since begining
porksniffer wrote:
wagyusteak wrote:
porksniffer wrote:
wagyusteak wrote:
porksniffer wrote:
wagyusteak wrote:
porksniffer wrote:
indoubtgetout wrote: Keep pulling out the text books mjm.   Better yet, the first thing an investor should do is look at a stock chart - a picture is worth a 1000 words they say.    Obviously you have not looked.  GUD has made shareholders SFA since its debut!!   Goodman was lucky with Paladin....not so much with GUD.   Either Goodman gets moving or shareholders will eventually just move.   I'd say best to just move on....Goodman is useless.   



In a sea of bullshittt posts this is the hard reality. But don't expect the couple of knobs in here pumping to ever change. It's a form of therapy, they can not acknowledge they have made a mistake after half a decade of being wrong in here. So they wait and wait and wait and hope, hope, hope for a repeat of the past that is fairly obvious to anyone that it's not going to happen.

The stock chart and stock returns tell the story, the market thinks this company will NOT be the next PDN, the 'throw darts at penny stock' strategies to companies in 3rd world conutries, their black hole acqusition in LATAM before the market collapsed, won't work out. No matter how high the earnings go, the CEO strategy of plunging shareholders into the hell hole that is LATAM this will trade at a large discount....forever. The sad part, everyting Meir had predicted would happen, has happened. Everything. 



Then why is Meir keeping the stock?? WHYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY?

then what happened to Paladin? an overnight success after 19 years. explain that to me. how did that happen? LOLL. 



Meir has agreed to four year standstill agreement. He can't just sell stock whenever he wants. Why not admit everything he predicted has happened? 

Stop comparing this to Palladin. Palladin started as a microcap with $100k sales and had LOTS of help from dad's Pharmascience shoveling rights to drugs. This will NOT be happening here, sales will not be quintipling in a year LOL.. law of big numbers prevents that. Oh and dad is no longer helping with drug rights. Not easy going at it alone now is it??
 


no, he can sell any time within 4 years. But his sales cannot affect the stock price. He predicted nothing. LOL. he wanted to use the money to make a venture by himself. LOL. 

JG got a lot of help from his dad?? lol. his dad gave him only $3mil and couple drug to sales and JG had to go on his own. What's the difference between that and JG asking endo for the voucher and Impadivo??? Did his dad tell him to ask Endo give him that too?? LOL. 

And btw, according to your logic, are they not father and son anymore? LOLLLLLL.

Now i can agree that GUD stock price cannot grow as fast as Pal's. But it will grow, especially when GUD can achieve what took Pal 19 years to achieve. LOL



In other words, Meir can't sell whenever he 'wants' to. Why not admit you are wrong?

JRG got $14 million from the 'parent'. And it was not 'couple of drugs' it was a DOZEN. You must be one of JRG buddies but please spare me the bullshitt. 


$14mil??? show me where did you get that? LOL. Meir can sell about 7000 shares a days everyday for the next 4 years. How about that? LOL
 



I'm not going to do your research for you. I'm calling you and your bullshitt out, you are wrong on both counts. And lol @ Meir allowed to sell 7000 shares/day. While you are doing your research on PDN you can look up what 4 year 'standstill agreement' means. Meir will most likely need to find a buyer for the entire block at a pre-agreed price. 


Read, idiot:

Archit Kshetrapal

I see. Okay. Great. And could you maybe share some additional color on the standstill agreement that's in place between Knight and Medison. Specifically, could you talk a little bit about the types of restrictions that are in place and perhaps when and how much Medison is allowed to sell?

Samira Sakhia

Sure. So as far as the standstill is concerned, there -- the issue is really more around are there any sort of shareholder activity, and that is -- he's no longer able to do anything like that. As part of selling the shares, he has the -- 4 years to sell, but more in a structured manner, so as to not impact the share price in any way.

Archit Kshetrapal

Okay. I see. Fantastic. And my guess -- my last question is are you seeing any particularly interesting M&A opportunities or business development opportunities in light of the current market environment and depressed valuations?


Bullboard Posts